D. E. Shaw & Co., Inc. Codexis, Inc. Transaction History
D. E. Shaw & Co., Inc.
- $114 Billion
- Q1 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Codexis, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 169,578 shares of CDXS stock, worth $602,001. This represents 0.0% of its overall portfolio holdings.
Number of Shares
169,578
Previous 911,138
81.39%
Holding current value
$602,001
Previous $2.78 Million
78.73%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding CDXS
# of Institutions
131Shares Held
48.9MCall Options Held
33.4KPut Options Held
21K-
Black Rock Inc. New York, NY6.61MShares$23.5 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.46MShares$15.8 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.26MShares$15.1 Million0.0% of portfolio
-
Baillie Gifford & CO3.45MShares$12.2 Million0.01% of portfolio
-
Opaleye Management Inc. Boston, MA3.12MShares$11.1 Million2.65% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $233M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...